acut
dissemin
encephalomyel
adem
immunemedi
disord
central
nervou
system
cn
affect
children
adult
estim
incid
adem
children
rang
without
ethnic
racial
predilect
studi
identifi
margin
higher
rate
adem
male
major
case
occur
children
age
year
younger
interestingli
rate
hospit
disord
increas
past
decad
pathogenesi
pathophysiolog
adem
fulli
understood
consist
propos
mechan
diseas
autoimmun
prime
environment
antigen
viru
bacteria
trigger
product
myelin
autoantigen
share
antigen
determin
caus
pathogen
histor
process
divid
two
phase
primingactiv
phase
recruit
phase
former
phase
defin
activ
expans
cell
spread
cn
latter
phase
product
cytokin
chemokin
activ
cell
recruit
addit
immun
cell
cn
lead
primari
injuri
white
matter
although
nuanc
describ
scope
review
author
focu
clinic
aspect
diseas
interfac
emerg
literatur
myelin
oligodendrocyt
glycoprotein
mog
antibodi
diagnosi
adem
base
histor
clinic
radiolog
find
singl
diagnost
test
consid
confirmatori
reason
pediatr
multipl
sclerosi
studi
group
gener
criteria
diagnosi
adem
aid
identif
condit
tabl
clinic
diagnosi
adem
difficult
symptom
often
variabl
frequent
polyfoc
onset
encephalopathi
defin
alter
mental
state
behavior
rang
coma
irrit
requir
diagnosi
children
degre
encephalopathi
vari
patient
may
depress
mental
statu
fact
younger
children
may
often
present
irrit
aggress
activ
behavior
chang
addit
neurolog
featur
includ
cerebellar
ataxia
cranial
neuropathi
hemiparesisweak
optic
neuriti
includ
vision
loss
pain
eye
movement
andor
affer
pupillari
defect
pyramid
dysfunct
spinal
cord
dysfunct
may
may
consist
transvers
myeliti
tm
disturb
languag
function
movement
disord
alter
sensorium
appreci
less
frequenc
associ
nonneurolog
find
includ
fever
meningismu
nauseavomit
gener
weak
presenc
area
postrema
syndrom
rare
may
indic
altern
diagnosi
neuromyel
optica
spectrum
disord
nmosd
neuroimmunolog
disord
patient
nonlifethreaten
febril
ill
day
prior
week
prior
neurolog
symptom
onset
previous
report
infect
includ
mycoplasma
viru
coronaviru
coxsacki
viru
hepat
herp
simplex
viru
human
immunodefici
viru
human
herpesviru
parainfluenza
viru
influenza
b
well
measl
mump
rubella
virus
minor
case
associ
vaccin
includ
limit
hepat
b
influenza
diphtheriapertussistetanu
measlesmumpsrubella
pneumococcu
polio
case
tradit
thought
less
sever
rare
convert
polyphas
diseas
major
patient
diagnos
adem
display
monophas
pattern
steadi
improv
return
neurolog
baselin
within
month
onset
symptom
differenti
diagnosi
child
present
polyfoc
neurolog
abnorm
encephalopathi
broad
viral
bacteri
meningitisenceph
must
rule
especi
presenc
fever
leukocytosi
lumbar
punctur
valuabl
rule
infect
differenti
diagnosi
cell
count
differenti
help
evalu
pleocytosi
white
blood
cell
wbc
present
neutrophil
lymphocyt
predomin
use
discrimin
bacteri
versu
viral
infect
respect
case
adem
cerebrospin
fluid
csf
wbc
count
rang
rare
report
beyond
latter
rang
mean
protein
count
csf
typic
normal
mildli
elev
gl
although
rang
broad
gl
glucos
level
csf
almost
uniformli
normal
gram
stain
cultur
provid
addit
specif
bacteri
infect
specif
viral
test
tailor
clinic
histori
although
infanc
metagenom
analysi
csf
becom
increasingli
util
mean
identifi
specif
infecti
agent
howev
turnaround
time
contamin
sampl
remain
problemat
data
limit
report
meningoenceph
associ
mog
antibodi
complic
even
earlier
interpret
set
noninfecti
csf
abnorm
white
matter
lesion
mri
brain
inflammatori
demyelin
disord
includ
multipl
sclerosi
ms
mog
antibodyassoci
demyelin
antibodyassoci
limbic
enceph
primari
angiiti
cn
malign
mitochondri
diseas
leukodystrophi
presenc
tm
may
occur
concurr
diagnos
context
neurolog
find
radiograph
find
note
nearli
demyelin
disord
childhood
includ
adem
link
presenc
mog
antibodi
past
year
test
serum
imper
diagnost
therapeut
purpos
test
antibodi
recommend
csf
interestingli
lower
sensit
serum
test
serum
test
perform
addit
test
cellbas
assay
recommend
antibodi
associ
nmosd
test
serum
well
therapeut
intervent
vari
dramat
popul
presenc
mog
antibodi
rare
prompt
retest
addit
diagnost
tool
consid
csf
test
oligoclon
band
ocb
immunoglobulin
g
igg
synthesi
index
former
present
less
frequent
patient
adem
although
present
associ
relaps
diseas
may
indic
altern
diagnos
longitudin
studi
children
adem
overal
rate
ocb
ocb
sensit
indic
adem
may
transient
present
present
acut
phase
use
context
less
sensit
indic
igg
index
anoth
marker
intrathec
igg
product
neopterin
indiscrimin
marker
intrathec
immun
activ
also
found
elev
varieti
inflammatori
cn
disord
although
specif
adem
less
util
case
given
establish
neuroimag
abnorm
discuss
later
addit
infecti
etiolog
autoimmun
paraneoplast
condit
differenti
diagnosi
clinic
present
subacut
encephalopathi
behavior
dysregul
past
two
decad
consider
amount
antibodyassoci
limbic
encephalitid
identifi
clinic
overlap
adem
broadli
describ
entiti
antinmda
receptor
antibodi
enceph
differenti
adem
featur
presenc
movement
disord
epilepsi
wax
wane
behavior
person
chang
autonom
instabl
languag
disturb
addit
cours
diseas
variabl
adem
present
multipl
week
even
month
limbic
encephalitid
consid
antihu
antigad
antiampa
antigaba
b
antigaba
receptor
antidppx
imag
disord
variabl
includ
medial
tempor
lobe
hyperintens
cortic
ribbon
white
matter
lesion
patient
present
statu
epilepticu
present
antibodi
thyroid
peroxidas
thyroglobulin
may
indic
hashimoto
encephalopathi
also
known
steroid
respons
encephalopathi
associ
autoimmun
thyroid
warrant
neuroimag
adem
classic
describ
diffus
poorli
demarc
bilater
lesion
involv
cerebr
white
matter
spine
exampl
typic
adem
neuroimag
display
fig
relaps
remit
disord
ms
may
initi
present
symptom
consist
adem
distinguish
adem
primari
present
ms
challeng
clinic
neuroimag
featur
may
indic
diagnosi
adem
rather
ms
includ
list
tabl
retrospect
studi
neuroimag
pediatr
patient
diagnos
adem
ms
callen
et
al
identifi
three
factor
predict
higher
likelihood
develop
ms
periventricular
lesion
presenc
black
hole
absenc
diffus
bilater
lesion
restrict
diffus
although
less
studi
neuroimag
patient
adem
mog
antibodi
also
report
import
differ
includ
widespread
distribut
lesion
increas
frequenc
longitudin
extens
lesion
spine
vertebr
segment
higher
likelihood
complet
revers
signal
subsequ
scan
patient
mog
antibodi
compar
idiopath
form
adem
distinguish
adem
mogassoci
adem
demyelin
disord
essenti
guid
therapi
provid
prognost
inform
patient
famili
intervent
disord
increasingli
nuanc
neuroradiolog
mimic
adem
includ
hypotens
encephalopathi
hemophagocyt
lymphohistiocytosi
primari
cn
lymphoma
system
rheumatolog
disord
system
lupu
erythematosu
behcet
diseas
sjogren
diseas
wegner
diseas
cn
vascul
granulomat
disord
neurosarcoidosi
genet
disord
leukodystrophi
although
differenti
made
physic
examin
clinic
histori
case
mention
previous
concept
relaps
adem
becom
increasingli
controversi
relapsingremit
demyelin
syndrom
need
continu
reevalu
author
encourag
caution
use
term
especi
absenc
mog
antibodi
advoc
indepth
exclus
altern
diagnos
ms
nmosd
ademon
clinic
demyelin
event
radiograph
chang
presenc
mog
antibodi
elev
pediatr
patient
adem
although
presenc
antibodi
specif
also
describ
ms
tm
nmosd
demyelin
disord
children
diagnos
adem
less
year
age
demyelin
disord
much
higher
rate
mog
antibodi
rate
report
high
although
appear
geograph
variat
incid
larg
studi
children
acquir
demyelin
event
higher
likelihood
mog
antibodi
posit
younger
patient
defin
year
highest
year
children
initi
demyelin
event
meet
criteria
adem
increas
csf
cell
count
neg
ocb
context
mog
antibodi
spectrum
disord
diagnosi
mogposit
adem
uniqu
first
rate
mog
antibodi
seroposit
much
higher
case
adem
case
nmosd
ci
ms
less
defin
demyelin
event
tm
studi
identifi
mog
antibodi
posit
factor
delin
nonm
clinic
cours
specif
antibodi
titer
use
anoth
studi
hacohen
et
al
identifi
mog
antibodi
seroposit
posit
predict
valu
nonmsrel
diseas
clinic
patient
mog
antibodi
seroposit
adem
similarli
heterogen
present
regard
neurolog
diseas
although
rate
report
higher
concurr
relaps
phenotyp
although
seizur
report
patient
adem
appear
mog
antibodyposit
patient
adem
may
increas
rate
seizur
present
longterm
risk
postadem
epilepsi
anoth
distinguish
characterist
compar
mog
antibodi
spectrum
disord
diagnost
children
mog
antibodyassoci
adem
report
increas
rate
larg
bilater
widespread
lesion
includ
brain
spinal
cord
longitudin
extens
tm
also
common
mog
antibodyassoci
adem
interestingli
follow
initi
immunotherapi
lesion
like
resolv
significantli
decreas
size
followup
scan
compar
nonmog
antibodyassoci
adem
mog
antibodi
spectrum
disord
presenc
mog
antibodi
adem
pose
longterm
monitor
challeng
patient
monophas
multiphas
form
report
monophas
ill
account
major
adem
mog
antibodyposit
case
associ
male
gender
younger
age
diagnosi
year
patholog
involv
optic
nerv
patient
like
seroconvert
neg
titer
emerg
evid
suggest
disord
may
fact
easier
treat
patient
mog
antibodi
posit
initi
diagnosi
adem
relaps
rate
report
high
patient
develop
multiphas
diseas
often
higher
antimog
antibodi
titer
older
present
may
refractori
typic
intervent
clinic
phenotyp
relaps
vari
includ
multiphas
adem
ademon
nmosd
relaps
interestingli
addit
attack
occur
age
increas
encephalopathi
less
frequent
appreci
although
new
neurolog
sign
radiograph
lesion
present
age
import
driver
relaps
risk
also
phenotyp
relaps
younger
patient
note
frequent
relaps
multiphas
adem
oppos
ademon
relaps
nmosd
collect
refer
opticospin
patholog
seroconvers
neg
titer
report
monophas
relaps
diseas
although
patient
continu
seroposit
note
higher
rate
polyphas
diseas
children
diagnos
antimogassoci
adem
concept
seroconvers
attract
although
link
less
sever
clinic
cours
monophas
diseas
time
increas
rate
relaps
seen
person
continu
mog
antibodi
posit
provid
insight
diffus
multifacet
inflammatori
natur
one
larg
studi
identifi
elev
esr
mmh
increas
csf
neutrophil
profil
indic
system
inflammatori
process
independ
age
similarli
complement
cascad
also
activ
mog
antibodydriven
diseas
also
system
implic
inflamm
well
remain
seen
organ
system
may
affect
person
longstand
mog
antibodi
diseas
time
intrathec
inflamm
also
present
increas
cytokin
respons
well
increas
intrathec
b
cell
respons
person
mog
antibodyposit
versu
neg
adem
respect
latter
find
interest
appear
mog
antibodi
insult
occur
antibodymedi
mechan
possibl
explain
variabl
phenotyp
neurodiagnost
studi
therapeut
respons
data
continu
evolv
mog
antibodyposit
diseas
initi
find
guid
current
therapeut
practic
mainstay
treatment
adem
intraven
iv
methylprednisolon
typic
administ
mgkgd
max
mgd
day
center
also
provid
oral
steroid
taper
week
data
support
practic
refractori
case
iv
immunoglobulin
ivig
typic
administ
gkg
day
gkg
day
plasma
exchang
demonstr
improv
patient
clinic
outcom
failur
glucocorticoid
although
latter
limit
adult
data
inform
regard
treatment
adem
antimog
antibodi
complex
limit
regard
largescal
studi
longterm
followup
patient
antimog
antibodi
posit
acut
demyelin
event
appear
respond
therapi
glucocorticoid
interestingli
patient
vulner
relaps
steroid
reduct
cessat
prompt
trial
multipl
form
immunotherapi
reason
prolong
slow
steroid
taper
often
util
anecdot
follow
initi
antimogassoci
demyelin
event
anecdot
author
appreci
increas
frequenc
relaps
set
lower
level
steroid
toward
end
taper
oppos
initi
portion
taper
calendar
although
data
unpublish
risk
versu
benefit
prolong
steroid
taper
children
need
care
weigh
current
practic
limit
prednison
taper
week
beyond
point
face
resurg
relaps
symptom
ivig
diseasemodifi
drug
may
consid
note
even
immunotherapi
initi
relaps
common
one
group
report
patient
relaps
within
month
diagnosi
averag
relaps
first
year
diseasemodifi
drug
interferon
glatiram
acet
evalu
patient
antimog
antibodi
posit
associ
clinic
improv
result
chang
annual
relaps
rate
expand
disabl
statu
scale
score
time
unlik
patient
nmosd
use
agent
appear
worsen
clinic
cours
attempt
mainten
therapi
includ
azathioprin
mycophenol
mofetil
rituximab
ivig
associ
reduct
relaps
patient
relaps
mog
antibodyposit
demyelin
disord
although
largescal
studi
need
prognosi
associ
adem
good
case
case
present
expectedli
determin
visual
disabl
repeat
neuroimag
even
rel
straightforward
case
month
present
instrument
risk
stratif
patient
regard
develop
ms
polyphas
neuroimmunolog
disord
later
time
point
although
mani
patient
focal
neurolog
deficit
recoveri
recent
data
suggest
one
less
appreci
longterm
sequela
adem
neurocognit
dysfunct
two
larg
seri
identifi
children
attentiondeficit
hyperact
disord
behavior
problem
learn
disabl
risk
factor
clinic
phenotyp
sever
neurolog
involv
present
older
age
male
gender
indic
like
link
neuroimmunolog
disord
etiolog
sequela
unclear
although
two
studi
demonstr
diminish
brain
volum
cortex
cerebellum
children
demyelin
event
possibl
acut
demyelin
attack
may
damag
matur
integr
exist
white
matter
critic
brain
point
develop
caus
longlast
neurocognit
effect
interestingli
prognosi
case
adem
associ
mog
antibodi
appear
somewhat
differ
studi
report
better
neurolog
outcom
nonmogassoci
adem
howev
patient
persist
mog
antibodi
may
like
develop
polyphas
disord
exist
convolut
spectrum
neuroimmunolog
disord
includ
multiphas
adem
adem
follow
nmosd
addit
potenti
postadem
epilepsi
also
seem
higher
group
although
larger
scale
longitudin
studi
need
sever
studi
ongo
better
defin
cours
treatment
monophas
multiphas
form
mog
antibodyassoci
diseas
long
character
adem
continu
move
target
regard
diagnost
therapeut
intervent
data
gather
etiolog
pathophysiolog
prolifer
inform
mog
antibodyassoci
adem
provid
clinician
addit
diagnost
therapeut
target
interim
although
much
research
need
target
person
intervent
futur
